date:Aug 10, 2012
ay the authors. However they suggest that tests of enzyme levels may be able to predict how an individual patient will respond.
The team also highlighted that received support from the US National Institutes of Health for the study and not from any pharmaceutical company saying that dose-finding studies arenot necessarily profitablefor pharmaceutical companies; particularly, they add, if the study outcome suggests lower doses than those recommended by the manufacturer after the drug has been